维普期刊资源整合服务平台（V6.5）

48篇 您的检索式：作者名="Hilger RA"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors显示文摘	STRUMBERG D RICHLY H HILGER RA	2005	J Clin Oncol2005，23，5：	1
2	Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors显示文摘	Strumberg D Richly H Hilger RA	2005	J Clin Oncol2005，23，：	1
3	Phase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY43-9006 in patients with advanced refractory solid tumors显示文摘	Strumberg D Richly H Hilger RA	2005	J Clin Oncol2005，23，5：	1
4	Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa显示文摘	Hilgers AR Conradi RA Burton PS	1990	Pharm Res1990，7，9：	1
5	The Ras-RafMEK-ERK pathway in the treatment of cancer显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Onkologie2002，25，6：	1
6	Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa 显示文摘	Hilgers AR Conradi RA Burton PS	1990	J Pharm Res1990，7，：	1
7	The Ras-Raf-MEK-ERK pathway in the treatment of cancer 显示文摘	Hilger RA Scheulen ME Strmnberg D	2002	Oncology2002，25，6：	1
8	The Ras-Raf-MEK- ERK pathway in the treatment of cancer显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Onkologie2002，25，6：	1
9	Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa显示文摘	Conradi RA Burton PS	1990	Pharm Res1990，7，9：	1
10	Phase Ⅰ clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 4-3-9006 in patients with advanced refractory solid tumors显示文摘	Strumberg D Richly H Hilger RA	2005	Journal of Clinical Oncology2005，23，5：	1
11	The Ras - Raf - MEK - ERK pathway in the treatment of cancer 显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Onkologie2002，25，6：	1
12	Phase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43 - 9006 in patients with advanced refractory solid tumors 显示文摘	Strumberg D Richly H Hilger RA	2005	J Clin Oncol2005，23，5：	1
13	The Ras-Raf-MEK-ERKpathway in the treatment of cancer显示文摘	Hilger RA ScheuLen ME Strumberg D	2002	Onkologie2002，25，6：	1
14	Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor jnbibjtorBAY 43-9006 in patients with advanced refractory solid tumors显示文摘	Strumberg D Richly H Hilger RA	2005	J Clin 0ncoi2005，23，：	1
15	Phase Ⅰ clinical and pharmacokinetic study of the novel Raf kinase and vascular endo2 thelial growth factor receptor inhibitor BAY4329006 in patients with advanced refractory solid tumors显示文摘	Strumberg D Richly H Hilger RA	2005	J Clin Oncol2005，23，：	1
16	Phase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43 -9006 in patients with advanced refractory solid tumors 显示文摘	Strumberg D Richly H Hilger RA	2005	J Clin Oncol2005，23，5：	1
17	The Ras-Raf-MEK-ERK pathway in the treatment of cancer显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Onkologie2002，25，6：	1
18	Phase Ⅰ clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY43- 9006 in patients with advanced refractory solid tumors显示文摘	STRUMBERG D RICHLY H HILGER RA	2005	J Clin Oncol2005，23，5：	1
19	The Ras-Raf_MEK、ERK pathway in the treatment of cancer显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Onkologie2002，25，6：	1
20	The Ras-Raf-MEK-ERK pathway in the treatment of cancer 显示文摘	Hilger RA Scheulen ME Strumberg D	2002	Onkologle2002，25，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示